NCT02224365

Brief Summary

The hypothesis of this study is that the daily consumption of 75 g dried apple powder for twelve weeks will improve arterial stiffness and blood pressure by improving endothelial-mediated vasodilation and vascular sympathetic activity and favorably altering biochemical markers associated with cardiovascular risk and glycemic control compared to a macronutrient-matched control powder. 50 men and women between the ages of 45 and 65 with prediabetes or type 2 diabetes who are overweight or obese will be included in the study. After a two-week run-in phase, eligible men and women will be randomly assigned to one of two treatment groups: 1) 75 g dried apple powder; or 2) 75 g placebo powder daily for twelve weeks. After an initial telephone screening, all participants will be requested to report to the study site for their first visit. On the first visit (screening), participants will be provided with verbal and written explanation of the project. They will then be asked to sign an informed consent form, followed by measuring fasting glucose levels and a medical history questionnaire to confirm prediabetes or type 2 diabetes. Baseline assessments will be performed for medical history, medication use, dietary intake, and physical activity. Qualified participants will be scheduled for their second visit two weeks later (actual baseline data collection) and randomly assigned to their treatment group. On the second (baseline) visit between the hours of 6:00-11:00 A.M., blood pressure and vascular function will be measured followed by blood draw and urine collection. Anthropometrics will be measured. Participants will be provided with their assigned treatment and will receive standard instructions on how to fill out daily diaries for their treatment, and for food and physical activity records. Blood pressure, vascular function, blood draw, urine collection, and anthropometric, body composition, diet, and physical activity assessments will be repeated at 6- (third visit), and 12-week (final visit) intervals. All cardiovascular measurements will be performed between 6:00 to 11:00 A.M., in a quiet temperature-controlled room in the supine position after an overnight fast and 12 hours after the abstinence of caffeine and/or 24 hours after the last bout of moderate to heavy physical activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_2 diabetes

Timeline
Completed

Started Aug 2014

Typical duration for phase_2 diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

August 21, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 25, 2014

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

December 8, 2016

Status Verified

December 1, 2016

Enrollment Period

2.3 years

First QC Date

August 21, 2014

Last Update Submit

December 6, 2016

Conditions

Keywords

DiabetesArterial StiffnessBlood PressureEndothelial FunctionBody CompositionGlycemic ControlApplesFunctional FoodsPolyphenolsFiber

Outcome Measures

Primary Outcomes (1)

  • Blood Pressure

    By measuring brachial and aortic blood pressure at rest and during physiological stress (handgrip exercise and post-exercise muscle ischemia).

    12 weeks

Secondary Outcomes (8)

  • Arterial Stiffness

    12 weeks

  • Autonomic Control of Blood Pressure

    12 weeks

  • Endothelial-mediated Vasodilation

    12 weeks

  • Inflammation

    12 weeks

  • Oxidative Stress

    12 weeks

  • +3 more secondary outcomes

Study Arms (2)

Apple

EXPERIMENTAL

12 weeks of 75 g dried apple powder taken in 480 ml per day.

Dietary Supplement: Apple

Placebo

PLACEBO COMPARATOR

12 weeks of 75 g apple-flavored placebo powder taken in 480 ml per day.

Dietary Supplement: Placebo

Interventions

AppleDIETARY_SUPPLEMENT

12 weeks of 75 g dried apple powder taken in 480 ml per day.

Apple
PlaceboDIETARY_SUPPLEMENT

12 weeks of 75 g apple-flavored placebo powder taken in 480 ml per day.

Placebo

Eligibility Criteria

Age45 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women (1 to 10 years postmenopausal)
  • Aged 45-65 years
  • Prediabetes or Type 2 Diabetes (Hemoglobin A1c ≥ 5.7%)
  • Overweight or obese (body mass index between 25 and 40 kg/m2)

You may not qualify if:

  • Diagnosed cardiovascular disease
  • Uncontrolled hypertension (≥ 160/100 mmHg)
  • Other active chronic diseases such as cancer, asthma, glaucoma, thyroid, kidney, liver and pancreatic disease
  • Participating in a weight loss program
  • Heavy smokers (\> 20 cigarettes per day)
  • Heavy drinkers (\> 12 alcoholic drinks per week)
  • Consumption of more than two apples per week
  • Body mass index less than 25 or greater than 40 kg/m2)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Nutrition, Food and Exercise Sciences, Center for Advancing Exercise and Nutrition Research on Aging, Florida State University

Tallahassee, Florida, 32306, United States

Location

MeSH Terms

Conditions

Diabetes MellitusCardiovascular DiseasesPrediabetic State

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Bahram H. Arjmandi, PhD, RD

    Department of Nutrition, Food and Exercise Sciences, Center for Advancing Exercise and Nutrition Research on Aging, Florida State University

    PRINCIPAL INVESTIGATOR
  • Arturo Figueroa, MD, PhD

    Department of Nutrition, Food and Exercise Sciences, Florida State University

    PRINCIPAL INVESTIGATOR
  • Sarah A. Johnson, PhD, RDN

    Department of Food Science and Human Nutrition, Colorado State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Margaret A. Sitton Professor

Study Record Dates

First Submitted

August 21, 2014

First Posted

August 25, 2014

Study Start

August 1, 2014

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

December 8, 2016

Record last verified: 2016-12

Locations